Cite
HARVARD Citation
Olivecrona, H. et al. (2013). OP0061 Kineret® (Anakinra) Controls Disease Symptoms in Patients with Severe Cryopyrin-Associated Periodic Syndromes (CAPS): Up to 5-Year Follow-Up Data. Annals of the rheumatic diseases. pp. A70-A71. [Online].